Alcami Corporation, a contract development and manufacturing organization (CDMO), has announced several strategic leadership appointments within its Drug Product team. These appointments will report directly to Tori E. Arens, President of Drug Product.

Scott Jedrey – Vice President, Oral Solid Dose Operations, Wilmington, NC

Scott Jedrey now leads Alcami’s Manufacturing and Packaging facilities in Wilmington, North Carolina. With a 35-year tenure at Alcami, Jedrey has held roles spanning Manufacturing and Quality Operations. His extensive knowledge and customer-focused leadership maintain Wilmington’s reputation for quality and excellence in oral solid dose manufacturing.

Jeff Tripp – Vice President, Sterile Operations, Research Triangle Park, NC

Jeff Tripp joins Alcami as site leader for the RTP facility in Morrisville, NC. With over 40 years of experience in Drug Product and Drug Substance Manufacturing, Tripp has held senior roles at Genentech/Roche, Allergan/AbbVie, and others. His expertise in sterile fill-finish, lyophilization, and lean manufacturing systems will drive innovation and efficiency at Alcami’s RTP site.

Tyler Ewald – Vice President, Sterile Operations, Charleston, SC

Tyler Ewald now leads the Charleston sterile manufacturing facility, bringing over 15 years of industry experience in a variety of leadership roles within manufacturing and packaging operations, including site operations. Prior to this role, he oversaw Wilmington’s Manufacturing and Packaging operations, where he demonstrated a servant leadership approach and a strong track record of transformational leadership. Ewald has worked across multiple dosage forms, including small and large volume sterile/terminally sterile products, oral solid dose, and semi-solids.

These appointments reflect Alcami’s strategic focus on delivering high-quality, life-changing therapies with agility, precision, and reliability.